Armin M. Koch

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States.

Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States.

Journal: European journal of heart failure

Published: August 05, 2026

Efficacy of digitoxin over time in patients with heart failure and reduced ejection fraction: further analysis of DIGIT-HF.

Efficacy of digitoxin over time in patients with heart failure and reduced ejection fraction: further analysis of DIGIT-HF.

Journal: European journal of heart failure

Published: July 23, 2026

DIGIT-HF: Results From the Win Ratio Analyses.

DIGIT-HF: Results From the Win Ratio Analyses.

Journal: Circulation. Heart failure

Published: May 28, 2026

Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial.

Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial.

Journal: European heart journal

Published: March 20, 2026

Comparison of three different hpv self-sampling tools - a subanalysis of the prospective, randomized hannover self-collection study.

Comparison of three different hpv self-sampling tools - a subanalysis of the prospective, randomized hannover self-collection study.

Journal: Archives of gynecology and obstetrics

Published: March 07, 2026

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.

Journal: The New England journal of medicine

Published: August 29, 2025

A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial.

A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial.

Journal: Pharmaceutical statistics

Published: June 08, 2025

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials.

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials.

Journal: European journal of heart failure

Published: March 27, 2025

Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial.

Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial.

Journal: BMJ open

Published: December 15, 2024

Randomization in phase II trials: No exemption based on sample size.

Randomization in phase II trials: No exemption based on sample size.

Journal: British journal of clinical pharmacology

Published: December 05, 2024

Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy.

Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology

Published: October 07, 2024

The DIGIT-HF trial: Key amendments of study design.

The DIGIT-HF trial: Key amendments of study design.

Journal: European journal of heart failure

Published: August 05, 2024

Showing 1-12 of 101

Last Updated: 09/26/2026